The FDA cleared Access MeMed BV, a host-response blood test that helps distinguish bacterial from viral infections in adults and children in as little as 15 minutes.
News|Slideshows|August 25, 2020
Poll: Give COVID-19 Vaccine to High-risk Americans First
Author(s)Grace Halsey
A Harris Poll finds Americans want a US-approved COVID-19 vaccine allocated here first, the rest of the world next, and our most vulnerable take priority.
Advertisement
If the first COVID-19 vaccine is approved in the US, most Americans say that vaccinating US citizens should be a priority before the vaccine is shared internationally and that within the US, those at high-risk for the infection and its complications should be the first to receive it.
Results of a
_________________________________________________________________________________
For more COVID-19 coverage for primary care, visit our COVID-19 Resource Page .
Advertisement
Related to this article
Catch up on the 9 FDA drug approvals most relevant to primary care, including new options for HIV-1 infection, narcolepsy, diabetes, pain management, and more.
Evolocumab was associated with a 20% lower risk of fatal or nonfatal myocardial infarction than ezetimibe among more than 544 000 adults with ASCVD.
Greater Mediterranean diet adherence was associated with lower odds of adult acne, particularly among women, in a UK Biobank study of dietary patterns.
Abbott's investigational device achieved 96.3% complete left atrial appendage closure by echocardiography, with a 1.8% ischemic stroke rate at 1 year.
October FDA news included updates on long-acting olanzapine, multi-cancer blood testing, stroke rehabilitation, and heart failure monitoring.
Christoph Correll, MD, discusses the new once-monthly olanzapine injection for schizophrenia, including clinical efficacy, metabolic risks, and patient selection.
Cheryl Cox Kinney, MD, explains when night sweats warrant further evaluation, including red flags, persistent symptoms, and potential nonmenopausal causes.
Advertisement
Advertisement